Diabetes Board decisions

The Veteran is granted an effective date of January 10, 2021, for the grant of service connection for chronic kidney disease with diabetic nephropathy and hypertension.

The Board denied the Veteran's claims for a higher rating for diabetes mellitus and a compensable rating for diabetic retinopathy, as the evidence did not support regulation of activities or documented incapacitating episodes.

The Board remands the claim for service connection for diabetes mellitus, type II to provide the Veteran with notice of his right to a pre-decisional hearing and to obtain an adequate medical opinion addressing secondary service connection.

The Board remands the issues of entitlement to service connection for diabetes mellitus type II, colon adenocarcinoma, and diabetic nephropathy due to a pre-decisional duty to assist error.

The appeal was dismissed as the Veteran withdrew all claims, including the instant appeal, on January 27, 2025.

The Board granted service connection for diabetes mellitus type II as secondary to the Veteran's service-connected disabilities and granted separate ratings for left knee instability, dislocated semilunar cartilage with frequent episodes of 'locking,' pain, and effusion, and limitation of extension. The appeal was denied for a higher rating for left knee instability and limitation of flexion.

The Board remands the claim for a new medical opinion to determine if the Veteran's diabetes had its onset in service or is caused or aggravated by his service-connected gouty arthritis.

The Board granted service connection for hypertension, diabetes mellitus, type II, right and left upper extremity neuropathy, right and left lower extremity neuropathy, and erectile dysfunction as secondary to the service-connected diabetes.

The Board denied service connection for diabetes mellitus, left leg disability (meralgia paresthetica and radiculopathy), left eye disability (cataracts, other than scar), cardiac disability, and cervical spine disability.

The Board granted service connection for hypertension, finding that the preexisting condition was aggravated by military service. The other claims were remanded for further development.

The Board denied service connection for a somatic symptom disorder disability and remanded claims for diabetes mellitus, right foot, left foot, left knee, and right knee disabilities.

The appeal was dismissed due to the Veteran's death while it was pending.

The Board denied the veteran's claim for service connection for diabetes mellitus, type II, finding that there was no evidence of a causal relationship between the condition and his active-duty service or exposure to contaminated water at Camp Lejeune.

The Veteran's claim for benefits under the Home Improvement and Structural Alterations (HISA) program to remodel the entrance of his home, including railings on both sides and replacement of carpet, was granted.

The Board granted service connection for coronary artery disease, diabetes mellitus, hypertension, diabetic nephropathy, and lower extremity diabetic peripheral neuropathy as secondary to the service-connected diabetes mellitus. The right and left upper extremity peripheral neuropathies were denied.

Eligibility for attorney fees based on past-due benefits awarded in an October 2023 rating decision is granted.

The Veteran's service-connected disabilities render him unable to secure and follow a substantially gainful occupation, warranting a total disability rating based on individual unemployability (TDIU).

The Board remands the matter for a referral to VA's Director of Compensation Service for extraschedular consideration of an effective date earlier than February 13, 2013, for TDIU and DEA benefits.

The Board remands the claims for service connection for diabetes mellitus and prostate cancer to correct a duty to assist error related to verifying the Veteran's exposure to herbicide agents while stationed in Korea.

The Board remands the claims for service connection for a neck injury, left shoulder injury, right shoulder injury, diabetes mellitus, and peripheral neuropathy as they require further development.